Borderline epithelial tumors of the ovary

被引:128
作者
Hart, WR
机构
[1] Cleveland Clin Fdn, Div Pathol & Lab Med, Cleveland, OH 44195 USA
[2] Cleveland Clin Lerner Coll Med, Dept Pathol, Cleveland, OH USA
关键词
borderline tumors; ovary; neoplasms; serous; mucinous;
D O I
10.1038/modpathol.3800307
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The concept and terminology of borderline epithelial tumors of the ovary have been controversial for over a century, in spite of the acceptance of a borderline category in almost all current classifications of ovarian tumors. Typically, borderline tumors are noninvasive neoplasms that have nuclear abnormalities and mitotic activity intermediate between benign and malignant tumors of similar cell type. Borderline tumors of all surface epithelial cell types have been studied. The most common and best understood are serous borderline tumors and mucinous borderline tumors of intestinal type, which are the subject of this review. Some of the most challenging issues for serous tumors include: the criteria and clinical behavior of stromal microinvasion; the high prevalence of synchronous extraovarian disease; the classification and histopathologic features of associated peritoneal tumor implants, especially invasive implants; and, the prognostic significance of micropapillary tumors. The mucinous borderline tumors of intestinal type have a different set of considerations, including: their frequently heterogeneous composition with coexisting benign, borderline and malignant elements; the classification and significance of accompanying noninvasive carcinoma; the recognition of stromal invasion, including microinvasion and expansile invasion; and, the historically misunderstood relationship to pseudomyxoma peritonei. All of these issues are discussed in this presentation, as are the important gross and microscopic features of serous and mucinous borderline tumors and pertinent information on their treatment and prognosis.
引用
收藏
页码:S33 / S50
页数:18
相关论文
共 104 条
[31]  
2-7
[32]   OVARIAN EPITHELIAL TUMORS OF BORDERLINE MALIGNANCY (CARCINOMAS OF LOW MALIGNANT POTENTIAL) [J].
HART, WR .
HUMAN PATHOLOGY, 1977, 8 (05) :541-549
[33]  
HART WR, 1992, GYNECOL ONCOL, P863
[34]   Primary ovarian mucinous cystadenocarcinomas - A clinicopathologic study of 49 cases with long-term follow-up [J].
Hoerl, HD ;
Hart, WR .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (12) :1449-1462
[35]   CYSTADENOFIBROMAS OF OVARY WITH EPITHELIAL ATYPIA [J].
KAO, GF ;
NORRIS, HJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1978, 2 (04) :357-363
[36]   Micropapillary serous carcinoma of the ovary: An immunohistochemical and mutational analysis of p53 [J].
Katabuchi, H ;
Tashiro, H ;
Cho, KR ;
Kurman, RJ ;
Ellenson, LH .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1998, 17 (01) :54-60
[37]   PROLIFERATIVE SEROUS TUMORS OF OVARY - HISTOLOGIC FEATURES AND PROGNOSIS [J].
KATZENSTEIN, ALA ;
MAZUR, MT ;
MORGAN, TE ;
KAO, MS .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1978, 2 (04) :339-355
[38]   Ovarian serous borderline tumors: The citadel defended [J].
Kempson, RL ;
Hendrickson, MR .
HUMAN PATHOLOGY, 2000, 31 (05) :525-526
[39]  
Kennedy AW, 1996, CANCER-AM CANCER SOC, V78, P278, DOI 10.1002/(SICI)1097-0142(19960715)78:2<278::AID-CNCR14>3.0.CO
[40]  
2-T